Citations

Showing 10 of 108081 citations.

Opportunistic Screening for Osteoporosis Using Hand Radiographs: A Preliminary Study
Mohammadi, Farid Ghareh , Sebro, Ronnie

Mayo Clinic

Studies in Health Technology and Informatics | May 19, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti230306 | PMID 37203534 Get It

Patients with low bone mineral density (BMD) are at risk for fractures however are often undiagnosed. Therefore, there is a need to opportunistically screen for low BMD in patients who present for other studies. This is a retrospective study of 812 patients aged 50 years or older who had dual-energy X-ray absorptiometry (DXA) and radiographs of the hands within 12 months of each other. This dataset was randomly split into training/validation (n=533) and test (n=136) datasets. A deep learning (DL) framework was used to predict osteoporosis/osteopenia. Correlations between the textural analysis of the bones and DXA measurements were obtained. We found that the DL model had an accuracy of 82.00%, sensitivity of 87.03%, specificity of 61.00% and an area under the curve (AUC) of 74.00% to detect osteoporosis/osteopenia. Our findings show that radiographs of the hand can be used to screen for osteoporosis/osteopenia and identify patients who should get formal DXA evaluation.
Interim Results of a Phase 1/2 Open‐Label Study of INO ‐3107 for HPV ‐6 and/or
Mau, Ted , Belafsky, Peter C. , Best, Simon R. , Friedman, Aaron D. , Lott, David G. , Paniello, Randal C. , Pransky, Seth M. , Howard, Tamara , Dallas, Michael, Patel, Aditya , Morrow, Matthew P. , Skolnik, Jeffrey M. , Best, Simon R , Friedman, Aaron D , Lott, David G , Paniello, Randal C , Mau, Ted , Amin, Milan R , Klein, Adam M. , Saba, Nabil F. , Howard, Tamara, Dallas, Michael J.

Mayo Clinic

The Laryngoscope | May 19, 2023 | Volume: 133 | Issue: 11 | Pages: 3087-3093

10.1002/lary.30749 | PMID 37204106 Get It

Objective To evaluate the safety, immunogenicity, and efficacy of INO‐3107, a DNA immunotherapy designed to elicit targeted T‐cell responses against human papillomavirus (HPV) types 6 and 11, in adult patients with recurrent respiratory papillomatosis (RRP; NCT04398433). Methods Eligible patients required ≥2 surgical interventions for RRP in the year preceding dosing. INO‐3107 was administered by intramuscular (IM) injection followed by electroporation (EP) on weeks 0, 3, 6, and 9. Patients underwent surgical debulking within 14 days prior to first dose, with office laryngoscopy and staging at screening and weeks 6, 11, 26, and 52. Primary endpoint was safety and tolerability, as assessed by treatment‐emergent adverse events (TEAEs). Secondary endpoints included frequency of surgical interventions post‐INO‐3107 and cellular immune responses. Results An initial cohort of 21 patients was enrolled between October 2020 and August 2021. Fifteen (71.4%) patients had ≥1 TEAE; 11 (52.4%) were Grade 1, and 3 (14.3%) were Grade 3 (none treatment related). The most frequently reported TEAE was injection site or procedural pain ( n = 8; 38.1%). Sixteen (76.2%) patients had fewer surgical interventions in the year following INO‐3107 administration, with a median decrease of 3 interventions versus the preceding year. The RRP severity score, modified by Pransky, showed improvement from baseline to week 52. INO‐3107 induced durable cellular responses against HPV‐6 and HPV‐11, with an increase in activated CD4 and CD8 T cells and CD8 cells with lytic potential. Conclusion The data suggest that INO‐3107 administered by IM/EP is tolerable and immunogenic and provides clinical benefit to adults with RRP. Level of Evidence 3 Laryngoscope , 133:3087–3093, 2023
Proteomic and Clinicopathologic Assessment of Penile Amyloidosis: A Single Institutional Review of 12 Cases
Gilani, Sarwat, Dasari, Surendra , Theis, Jason D. , Dao, Linda N. , Cubilla, Antonio L. , Hernandez, Loren P. Herrera , Jiménez, Rafael E. , Cheville, John C. , Howard, Matthew T., Guo, Ruifeng , Gupta, Sounak , Gilani, Sarwat I, Herrera Hernandez, Loren P, Guo, Ruifeng , Tekin, Burak , Rech, Karen L. , Dispenzieri, Angela , McPhail, Ellen Darcy , Erickson, Lori A

Mayo Clinic

American Journal of Clinical Pathology | May 19, 2023 | Volume: 160 | Issue: 3 | Pages: 303-313

10.1093/ajcp/aqad054 | PMID 37203248 Get It

Abstract Objectives There is a paucity of data on penile amyloidosis. We aimed to assess the frequency of different amyloid types in surgical specimens from the penis involved by amyloidosis and correlate relevant clinicopathologic parameters with proteomic findings. Methods Since 2008, our reference laboratory has performed liquid chromatography/tandem mass spectrometry (LC-MS/MS) for amyloid typing. The institutional pathology archive and reference laboratory database were queried to retrospectively identify all penile surgical pathology specimens with LC-MS/MS results between January 1, 2008, and November 23, 2022. Archived H&E-stained and Congo red–stained sections were re-reviewed. Results Twelve cases of penile amyloidosis were identified, which represented 0.35% (n = 3,456) of penile surgical specimens. AL-type amyloid was most frequent (n = 7), followed by keratin-type amyloid (n = 3) and ATTR (transthyretin)–type amyloid (n = 2). AL-type amyloid cases often showed diffuse dermal/lamina propria deposition, whereas all keratin-type amyloid cases were localized to the superficial dermis. Two cases with keratin-type amyloid had concomitant cutaneous findings (penile intraepithelial neoplasia and condyloma). Conclusions This series, the largest to date, demonstrates that penile amyloidosis has a heterogeneous proteomic landscape. To the best of our knowledge, this is the first study describing ATTR (transthyretin)–type penile amyloid.
Brain Bank Questionnaire Helps in Differential Diagnosis of Movement Disorders: An Autopsy Study of 150 Patients
Martin, Nicholas B. , Sekiya, Hiroaki , Kim, Minji , Koga, Shunsuke , Kim, Minji , Koga, Shunsuke , Sekiya, Hiroaki , Dickson, Dennis W.

Mayo Clinic

Movement Disorders Clinical Practice | May 19, 2023 | Volume: 10 | Issue: 7 | Pages: 1131-1135

10.1002/mdc3.13788 | PMID 37476322 Get It

ABSTRACTBackgroundAs part of the CurePSP brain donation program, a questionnaire was developed to gather basic clinical information on donors; however, its usefulness has not been evaluated.ObjectiveTo assess the value of information obtained from the questionnaire in differentiating between parkinsonian disorders.MethodsWe reviewed 150 questionnaires, including 50 patients, each with a neuropathologic diagnosis of Lewy body disease (LBD), multiple system atrophy (MSA), or progressive supranuclear palsy. The frequency of clinical features recorded in the questionnaires was compared for the three disorders, and a machine learning algorithm was used to identify features predicting neuropathologic diagnosis.ResultsThe information from the questionnaires correlated with core clinical features for each disorder, such as hallucinations for LBD and autonomic dysfunction for MSA. Hallucinations and disorientations were identified as the key variables that contributed most to the prediction of neuropathology.ConclusionThe questionnaire provides useful clinical information for clinicopathological correlative studies.
Opportunistic Screening for Osteoporosis Using CT Scans of the Knee: A Pilot Study
Elmahdy, Mahmoud , Sebro, Ronnie

Mayo Clinic

Studies in Health Technology and Informatics | May 19, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti230305 | PMID 37203533 Get It

Knee CT scans are used for planning for total knee arthroplasties in patients who are often simultaneously at risk for frailty fractures due to low bone mineral density. We retrospectively identified 200 patients (85.5% female) with concurrent CT scans of the knee and Dual energy x-ray absorptiometry (DXA). The mean CT attenuation of the distal femur, proximal tibia and fibula, and patella, were calculated using volumetric 3-dimensional segmentation using 3D Slicer. Data were split randomly into training 80% and test 20% datasets. The optimal CT attenuation threshold for the proximal fibula was obtained in the training dataset and evaluated in the test dataset. A support vector machine (SVM) with radial basis function (RBF) using C-classification was trained and tuned using 5-fold cross-validation in the training dataset and then evaluated in the test dataset. The SVM had a higher area-under-the curve (AUC) of 0.937 and better performance to detect osteoporosis/osteopenia than the CT attenuation of the fibula (AUC of 0.717) (P=0.015). Opportunistic screening for osteoporosis/osteopenia could be accomplished using CT scans of the knee.
Pericardial effusions: perspective of the acute cardiac care physician
Jain, C. Charles , Reddy, Yogesh N.V. , Nishimura, Rick

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | May 19, 2023 | Volume: 12 | Issue: 7 | Pages: 467-474

10.1093/ehjacc/zuad050 | PMID 37202863 Get It

Abstract Pericardial effusions can result in acute haemodynamic compromise and require rapid intervention. Understanding pericardial restraint is essential to determine the approach to newly identified pericardial effusions in the intensive care unit. As pericardial effusions stretch the pericardium, the pericardial compliance reserve is eventually exhausted, with an exponential rise in compressive pericardial pressure. The severity of pericardial pressure increase depends on both the rapidity and volume of pericardial fluid accumulation. This increase in pericardial pressure is reflected in an increase in measured left- and right-sided ‘filling’ pressures, but paradoxically left ventricular end-diastolic volume (the true left ventricular preload) is decreased. This uncoupling of filling pressures and preload is the hallmark of pericardial restraint. When this occurs acutely from a pericardial effusion, rapid recognition and pericardiocentesis can be lifesaving. In this review, we will discuss the haemodynamics and pathophysiology of acute pericardial effusions, provide a physiological guide to determine the need for pericardiocentesis in acute care, and discuss important caveats to management.
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
Kim, Beom Kyung , Bergstrom, Jaclyn , Loomba, Rohan, Tamaki, Nobuharu , Izumi, Namiki , Idılman, Ramazan , Gümüşsoy, Mesut , Erden, Ayşe , Yang, Ju Dong , Noureddin, Mazen , Loomba, Rohit , Ajmera, Veeral , Idilman, Ramazan , Nakajima, Atsushi , Öz, Diğdem Kuru , Truong, Emily , Yang, Ju Dong , Allen, Alina M. , Loomba, Rohit , Ajmera, Veeral

Mayo Clinic

Hepatology | May 19, 2023 | Volume: 78 | Issue: 6 | Pages: 1858-1866

10.1097/hep.0000000000000470 | PMID 37203233 Get It

Background and Aims: Magnetic resonance elastography (MRE) is an accurate, continuous biomarker of liver fibrosis; however, the optimal combination with clinical factors to predict the risk of incident hepatic decompensation is unknown. Therefore, we aimed to develop and validate an MRE-based prediction model for hepatic decompensation for patients with NAFLD. Approach and Results: This international multicenter cohort study included participants with NAFLD undergoing MRE from 6 hospitals. A total of 1254 participants were randomly assigned as training (n = 627) and validation (n = 627) cohorts. The primary end point was hepatic decompensation, defined as the first occurrence of variceal hemorrhage, ascites, or HE. Covariates associated with hepatic decompensation on Cox-regression were combined with MRE to construct a risk prediction model in the training cohort and then tested in the validation cohort. The median (IQR) age and MRE values were 61 (18) years and 3.5 (2.5) kPa in the training cohort and 60 (20) years and 3.4 (2.5) kPa in the validation cohort, respectively. The MRE-based multivariable model that included age, MRE, albumin, aspartate aminotransferase, and platelets had excellent discrimination for the 3- and 5-year risk of hepatic decompensation (c-statistic 0.912 and 0.891, respectively) in the training cohort. The diagnostic accuracy remained consistent in the validation cohort with a c-statistic of 0.871 and 0.876 for hepatic decompensation at 3 and 5 years, respectively, and was superior to Fibrosis-4 in both cohorts (p < 0.05). Conclusions: An MRE-based prediction model allows for accurate prediction of hepatic decompensation and assists in the risk stratification of patients with NAFLD.
Severity of the Omicron SARS‐CoV ‐2 variant compared with the previous lineages: A systematic review
Arabi, Maryam , Al‐Najjar, Yousef , Mhaimeed, Nada , Salameh, Mohammad , Paul, Pradipta , AlAnni, Jamal, Abdelati, Ali, Laswi, Ibrahim , Khanjar, Bushra, Al‐Ali, Dana , Mhaimeed, Omar, Burney, Zain, D’Souza, Ashton, Sinha, Pratyaksha, Bhatti, Mohammad, Pillai, Krishnadev V., Homssi, Moayad, Bshesh, Khalifa , Yagan, Lina, Salameh, Mohammad A , Elshafeey, Abdallah , Zakaria, Dalia , Alanni, Jamal, Pillai, Krishnadev V., Homssi, Moayad, Zakaria, Dalia

Mayo Clinic

Journal of Cellular and Molecular Medicine | May 19, 2023 | Volume: 27 | Issue: 11 | Pages: 1443-1464

10.1111/jcmm.17747 | PMID 37203288 Get It

Abstract The Omicron variant was first detected in October 2021, which evolved from the original SARS‐CoV‐2 strain and was found to possess many mutations. Immune evasion was one of the notable consequences of these mutations. Despite Omicron exhibiting increased transmissibility, the rates of hospitalizations and deaths among patients infected with this variant were substantially lower when compared to other strains. However, concluding that the Omicron variant is less severe than other variants of SARS‐CoV‐2 requires consideration of multiple factors, including the vaccination status of infected patients as well as any previous infections with other variants. This review compiled data about any reported indicators of severity in Omicron‐infected patients, including studies comparing Omicron with other variants while adjusting for confounders. A comprehensive search was conducted using different databases to target any studies about Omicron. In total, 62 studies met our inclusion criteria and were included in this study. Many studies reported a significantly reduced risk of hospitalization, ICU admission, need for oxygenation/ventilation, and death in Omicron‐infected patients compared to patients infected with other variants, such as Delta. Some studies, however, reported comparable severity in Omicron infected patients as to other variants emphasizing a substantial risk for severe illness. Furthermore, the COVID‐19 vaccines were less effective against Omicron relative to previous lineages, except after receiving the booster dose. One study recommended vaccination during pregnancy, which may help prevent future cases of severe SARS‐CoV‐2 pneumonia in neonates and young infants due to the transfer of humoral response from the mother.
Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study
Jadoon, Sarosh Khan , Soomro, Rufina , Khan, Raja Muhammad Ijaz , Iqbal, Sadia, Yasmin, Farah , Najeeb, Hala , Cho, Namiya, Resham, Hasan, Syeda Fatima Saba , Khalid, Muhammad Zain , Alvi, Sarosh , Rizvi, Ahsan Mujtaba, Asghar, Muhammad Sohaib , Ahsan, Muhammad Nadeem , Saleem, Nida , Shaikh, Taha Gul , Alvi, Sarosh , Rizvi, Ahsan Mujtaba

Mayo Clinic

Medicine | May 18, 2023 | Volume: 102 | Issue: 20 | Pages: e33811

10.1097/md.0000000000033811 | PMID 37335707 Get It

Inflammatory conditions play part in the progression of malignancies, and markers signifying growth of these factors can indicate prognosis. Neutrophil-to-lymphocyte (NLR) is used as a marker of subclinical inflammation that may become an integral part of workup to indicate prognosis and associated pathology. This study aims to explore the association of NLR ratio with clinical characteristics, radiological assessment and staging, histopathology, and disease outcomes of breast cancer. A retrospective cohort study was conducted in a tertiary care center to include breast cancer patients that were diagnosed between January 2001 and December 2020. Data including tumor size, lymph nodes, metastasis, histological grading, ER/PR/HER2-neu status, molecular subtypes, clinical staging); nodal findings (sentinel and axillary); pathology from frozen section; and disease outcomes were assessed. Multivariable regression and Kaplan–Meier survival curves were employed to indicate the association of NLR with breast cancer features and disease-free survival. A total of 2050 patients had a median age of 50 years, median NLR levels of 2.14, most common pathology ductal followed by lobular, and most common site of metastasis being lungs followed by bones. Disease-free rate was 7.6%, and a recurrence rate of 1.8%, while 1.6% deaths were reported. NLR was found associated with age, treatment outcomes, tumor size, lymph nodes, metastasis and clinical staging. Other positive correlations were with Ki67 proliferation index, molecular subtypes, and tumor size on frozen section (at transverse and craniocaudal dimensions). Negative correlations were seen with estrogen and progesterone receptors. However, NLR was not found predictable of disease-free survival (P = .160). Significant predictors of disease-free survival were histological grading, ER, PR status, molecular subtype, and Ki67 proliferation index. NLR being a readily available marker has shown novel findings in its association with tumor staging, disease outcomes and characteristics of breast malignancy.
Effect of Fetal Surgery on Maternal Mental Health [ID: 1376946]
Larish, Alyssa , Betcher, Hannah K. , Liseth, Olivia , Moore, Katherine M. , Schenone, Mauro , Schenone, Mauro H , Weng, Jessica

Mayo Clinic

Obstetrics & Gynecology | May 18, 2023 | Volume: 141 | Issue: 5S | Pages: 87S-87S

10.1097/01.aog.0000931048.06184.77 Get It

INTRODUCTION: Perinatal mental illness imparts a significant health burden. A multitude of factors are hypothesized to increase the incidence of perinatal mood and anxiety disorders (PMADs) in the fetal surgical population, including uncertain fetal prognosis and the inherent risks of surgery and preterm delivery. We sought to determine the disease course of PMADs in the fetal surgery population. METHODS: A retrospective chart review was conducted of fetal surgery patients from 2017 to 2021 at a tertiary care center. Demographics, surgical, obstetric, and psychiatric diagnoses were recorded. Standard descriptive analyses were performed. RESULTS: One hundred nineteen eligible patients were identified. Fetal surgery was performed at a median gestational age of 23.0 (range 16.0–34.0) weeks. Laser ablation of placental anastomoses (n=51) and in utero myelomeningocele repair (n=22) were the most common procedures. 26.8% (32/119) had preexisting mood disorders, with 59.3% (19/32) and 53.1% (17/32) on a baseline medication for depression or anxiety, respectively, prior to surgery. 26.4% (23/87) of patients without a history of anxiety or depression had a new diagnosis of PMAD. Two patients experienced suicidal ideation. 6.7% (8/119) and 10.1% (12/119) initiated a new psychiatric medication during or post-pregnancy, respectively. 19.8% (21/113) received a therapy referral. Among patients with baseline anxiety or depression, 62.5% (20/32) experienced an exacerbation postpartum with 25.0% (8/32) referred for therapy, and 34.3% (11/32) changing dose or medication for anxiety and 37.5% (12/32) for depression. CONCLUSION: Among patients undergoing fetal surgery, a high incidence of PMAD was identified. Most patients with prepregnancy anxiety or depression experienced an exacerbation postpartum. Further research into effective supportive interventions is warranted.